Following the admission by the multinational pharmaceutical company AstraZeneca in a UK court that, in rare circumstances, its Covid vaccine can result in blood clots, a group of physicians on Thursday voiced serious concerns about the safety of the Covishield...
Know More
AAP leader, Delhi Minister Saurabh Bharadwaj expressed concern on Wednesday regarding the Indian government's persistent promotion of the Covishield vaccine despite reports suggesting potential side...
Know More
Former ICMR scientist Dr. Raman Gangakhedkar has said that only a small fraction of individuals, approximately seven to eight out of every 10 lakh recipients...
Know More
A report from The Telegraph reveals that AstraZeneca, the manufacturer of the Covishield vaccine, has admitted for the first time in court documents that the...
Know More
AstraZeneca, a prominent British pharmaceutical company, has acknowledged that its Covid-19 vaccine may lead to a rare side effect identified as Thrombosis with Thrombocytopenia Syndrome...
Know More
47,500 doses of Covishield and 18,600 doses of Covaxin are available at all Primary Health Centres, Community Health Centres, Taluk Hospitals, District Training Institutes, McGANN...
Know More
The Telangana government has urged the Centre to provide 50 lakh doses of Covid-19 vaccines to expedite the vaccination programme in the...
Know More
Ahead of the opening of the booster drive for all the 18 plus range, vaccine manufacturer Serum Institute of India has announced a considerable reduction...
Know More
The National Technical Advisory Group on Immunisation (NTAGI) has recommended reducing the gap between the first and second dose of Covid vaccine...
Know More
As of now as many as 110 countries have recognized India's Covid vaccines -- Covishield and Covaxin -- and have agreed to mutual recognition of...
Know More
If Covishield gets the approval for regular market authorisation from DCGI, it will be the second vaccine in the world to receive such...
Know More
Get latest news karnataka updates on your email.
